SunGlowInnovations

SunGlow Innovations VETERINARY RESEARCH

Companion animal tumor research

The veterinary program studies an investigational approach to image-guided local delivery in dogs and cats with spontaneous tumors.

Illustrative portrait of a golden retriever and a gray tabby cat
AI-generated illustration of a dog and cat
U.S. VETERINARY FILECVM INAD I-014155
PROGRAM STATUSInvestigational development
PUBLIC ENROLLMENTStudy preparation

What the program is studying

Target lesion and distribution

Study how imaging can document lesion location and the distribution of investigational local delivery.

Target-animal safety

Characterize adverse events, local tissue reactions and tolerability in veterinary studies.

Follow-up and local changes

Plan consistent assessments of local tissue changes and clinical signs over time.

HISTORICAL OBSERVATIONS

What the case records show

The investigator brochure summarizes 22 animals with spontaneous tumors: 19 dogs and 3 cats. Clinical signs and local tissue changes varied by case.

The case records document the course of local tissue changes, including necrosis, tissue separation and healing. These observations guide the veterinary program’s assessment of local response, tolerability and duration of control.

Source: Investigator’s Brochure, section 5.

CVM INAD I-014155

Veterinary development status

The veterinary program is exploring intratumoral research in companion animals with spontaneous solid tumors, including dogs and cats. Study design and veterinary collaborations are in development.

CVM receipt date for the INAD opening submission

Submitted the expanded conditional approval (XCA) eligibility request. The CVM portal shows that the center sent a response.

Submitted target animal safety (TAS) materials for chlorine dioxide injection in dogs and cats. The CVM portal shows that the center sent a response.

The CVM receipt identifies SunGlow Innovations LLC and the investigational file. FDA evaluates animal-drug authorization and any marketing application separately.

2027 U.S. veterinary development roadmap

Sponsor forecast for INAD I-014155 covering XCA eligibility, target animal safety, manufacturing, CMC, effectiveness and the conditional approval application.
Accelerated scenario forecast prepared by the sponsor. The dates are planning targets and FDA determines the review outcome and timing. View full-size roadmap

For pet owners and veterinary teams

Study sites and participation criteria will be posted when confirmed. For a pet’s current diagnosis or care, speak with its veterinarian or veterinary oncologist.

Company and research collaboration